Hepatocellular-carcinoma-related protein-1 (HCRP-1) is known to be downregulated in various malignant tumors, and its downregulation induces anoikis resistance via Bim downregulation in the EGFR–Akt pathway [36]. This evidence concerns the gene BCL2L11 and cancer.